Hinge Health (HNGE) drew fresh attention after its share price closed at $114.32. Recent returns over the past month and past 3 months sharply outpaced its single day decline.
For context, Hinge Health has shown strong momentum over a longer stretch, with a 30-day share price return of 17.56%, a 90-day gain of 53.02% and a year-to-date share price move of 150.92%, while the 1-year total shareholder return sits at 129.74%.
Scan beyond Hinge Health and size up other fast moving candidates with 18 high quality undiscovered gems for your watchlist.
After Hinge Health’s rapid run and tiny gap to the latest analyst target, the bigger swing now lies in intrinsic value estimates. Does fair value cluster near today’s price, or is it closer to that far deeper discount signal?
Most Popular Narrative: 21.2% Undervalued
On the most followed view, Hinge Health screens at a fair value of $145.04 against a last close of $114.32, which puts the spotlight on how durable its current business engine really is.
Hinge Health has quickly distinguished itself as one of the most successful IPOs of 2025, combining rapid revenue growth, widening margins, and a scalable AI‑driven care model. The company’s focus on musculoskeletal (MSK) health; covering prevention, acute injury, chronic pain, and post‑surgical recovery, has resonated with employers and insurers, driving adoption across millions of contracted lives.
Find out how 3 investors see Hinge Health as 21% undervalued.
Based on that narrative, Hinge Health is treated as trading at a meaningful discount to an assessed fair value of $145.04, with the gap framed by a discount rate of 7.236% applied to its future cash flows.
Result: Fair Value of $145.04 (UNDERVALUED)
Still, the bullish Hinge Health story can crack if rich valuation meets any regulatory setback on healthcare compliance or if large employer customers start to pull back.
Find out about the key risks to this Hinge Health narrative.
Another View: Hinge Health Through A P/E Lens
The DCF narrative paints Hinge Health as attractively priced, yet the earnings multiple tells a very different story. HNGE trades on a P/E of 86x, compared with 25.3x for the wider US Healthcare sector and 63.8x for peers, while the fair ratio is 38.2x. That gap points to meaningful valuation risk if sentiment cools or earnings disappoint.
For investors who want to understand how that premium could compress or hold, and what the earnings profile needs to justify it, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Sentiment around Hinge Health is clearly upbeat, so treat that as a starting point rather than an answer and pressure test the numbers yourself today. If you want a quick snapshot of what the market views as the main upsides, take a look at 3 key rewards.
Looking for more Hinge Health investment ideas?
Do not stop at Hinge Health. Broaden your watchlist with focused stock ideas that match the way you like to assess risk, value, and income potential.
- Spot potential bargains early by scanning a curated pool of quality value candidates through 29 high quality undervalued stocks.
- Strengthen capital preservation goals by filtering for companies highlighted as 30 resilient stocks with low risk scores.
- Build dependable income streams by targeting payout opportunities from 5 dividend fortresses.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com